$QUBT
Quantum Computing Inc. Stock $qubt

$qubt Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000121390023067059 Filed on August 14, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$50.44K	$112.2K
YoY Change	33.97%	71.32%
Cost Of Revenue	$23.72K	$51.16K
YoY Change	-4.7%	877.58%
Gross Profit	$26.71K	$61.03K
YoY Change	109.44%	1.3%
Gross Profit Margin	52.97%	54.4%
Selling, General & Admin	$2.365M	-$325.4K
YoY Change	-13.09%	-115.64%
% of Gross Profit	8853.83%	-533.1%
Research & Development	$1.698M	$1.585M
YoY Change	34.1%	86.34%
% of Gross Profit	6357.71%	2596.48%
Depreciation & Amortization	$610.0K	$60.32K
YoY Change	-59.7%	-76.27%
% of Gross Profit	2283.45%	98.83%
Operating Expenses	$7.694M	$3.920M
YoY Change	12.38%	-19.48%
Operating Profit	-$7.668M	-$3.859M
YoY Change	12.2%	-19.74%
Interest Expense	-$390.0K	-$568.2K
YoY Change	-23.85%	677.44%
% of Operating Profit
Other Income/Expense, Net	-$608.4K	-$783.4K
YoY Change	-17.26%	164.46%
Pretax Income	-$8.280M	-$4.642M
YoY Change	9.39%	-9.05%
Income Tax
% Of Pretax Income
Net Earnings	-$8.276M	-$4.642M
YoY Change	9.34%	-9.05%
Net Earnings / Revenue	-16409.08%	-4138.02%
Basic Earnings Per Share	-$0.11	-$0.07
Diluted Earnings Per Share	-$0.09	-$0.05
COMMON SHARES
Basic Shares Outstanding	74.30M shares	61.51M shares
Diluted Shares Outstanding	96.65M shares	88.94M shares

Balance Sheet

Concept	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.380M	$7.197M
YoY Change	-28.91%	6.73%
Cash & Equivalents	$7.379M	$7.197M
Short-Term Investments
Other Short-Term Assets	$17.34K	$11.57K
YoY Change	-98.98%	-97.88%
Inventory
Prepaid Expenses	$167.2K	$202.2K
Receivables	$2.435K	$121.4K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$8.110M	$8.037M
YoY Change	-33.38%	9.02%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.958M	$1.451M
YoY Change	878.53%	804.9%
Goodwill	$64.92M	$65.11M
YoY Change	9.8%	10.12%
Intangibles	$12.10M	$12.81M
YoY Change	-49.0%	-49.21%
Long-Term Investments
YoY Change
Other Assets	$78.26M	$79.16M
YoY Change
Total Long-Term Assets	$81.22M	$80.61M
YoY Change	-2.32%	-4.61%
TOTAL ASSETS
Total Short-Term Assets	$8.110M	$8.037M
Total Long-Term Assets	$81.22M	$80.61M
Total Assets	$89.33M	$88.65M
YoY Change	-6.29%	-3.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.131M	$935.4K
YoY Change	27.32%	23.62%
Accrued Expenses	$1.030M	$2.828M
YoY Change	52.97%	854.82%
Deferred Revenue
YoY Change
Short-Term Debt	$4.510M	$6.516M
YoY Change	741.92%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$8.089M	$11.74M
YoY Change	123.07%	803.51%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change	-100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.089M	$11.74M
Total Long-Term Liabilities
Total Liabilities	$8.089M	$11.74M
YoY Change	-27.42%	803.51%
SHAREHOLDERS EQUITY
Retained Earnings	-$141.4M	-$133.1M
YoY Change	39.73%	42.19%
Common Stock	$7.510K	$6.724K
YoY Change	121.53%	130.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$81.24M	$76.91M
YoY Change
Total Liabilities & Shareholders Equity	$89.33M	$88.65M
YoY Change	-6.29%	-3.52%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	-$8.276M	-$4.642M
YoY Change	9.34%	-9.05%
Depreciation, Depletion And Amortization	$610.0K	$60.32K
YoY Change	-59.7%	-76.27%
Cash From Operating Activities	-$4.850M	-$5.072M
YoY Change	62.01%	15.87%
INVESTING ACTIVITIES
Capital Expenditures	$1.580M	$202.6K
YoY Change	-1111.98%	-100.34%
Acquisitions
YoY Change
Other Investing Activities	-$60.00K	-$508.6K
YoY Change	-95.22%	-97.91%
Cash From Investing Activities	-$1.640M	-$711.2K
YoY Change	16.29%	-99.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	6.670M	6.216M
YoY Change	-17.07%	-92.53%
NET CHANGE
Cash From Operating Activities	-4.850M	-5.072M
Cash From Investing Activities	-1.640M	-711.2K
Cash From Financing Activities	6.670M	6.216M
Net Change In Cash	180.0K	431.9K
YoY Change	-95.05%	-109.05%
FREE CASH FLOW
Cash From Operating Activities	-$4.850M	-$5.072M
Capital Expenditures	$1.580M	$202.6K
Free Cash Flow	-$6.430M	-$5.275M
YoY Change	126.61%	-109.61%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40615
	dei	Entity Registrant Name EntityRegistrantName	QUANTUM COMPUTING INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-4533053
	dei	Entity Address Address Line1 EntityAddressAddressLine1	215 Depot Court SE,
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 215
	dei	Entity Address City Or Town EntityAddressCityOrTown	Leesburg
	dei	Entity Address State Or Province EntityAddressStateOrProvince	VA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20175
	dei	City Area Code CityAreaCode	(703)
	dei	Local Phone Number LocalPhoneNumber	436-2121
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	dei	Security12b Title Security12bTitle	Common Stock, par value $.0001
	dei	Trading Symbol TradingSymbol	QUBT
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	74296370	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7196795	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5308466	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	121389	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	12774	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	202168	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	224302	usd
CY2023Q2	us-gaap	Loans Receivable With Fixed Rates Of Interest1 LoansReceivableWithFixedRatesOfInterest1	504668	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	11567	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	42105	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	8036587	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	5587647	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1451364	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	975169	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1178933	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1327746	usd
CY2023Q2	us-gaap	Security Deposit SecurityDeposit	64218	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	60271	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12810010	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	22223725	usd
CY2023Q2	us-gaap	Goodwill Goodwill	65106678	usd
CY2022Q4	us-gaap	Goodwill Goodwill	59125773	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	79159839	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	82737515	usd
CY2023Q2	us-gaap	Assets Assets	88647790	usd
CY2022Q4	us-gaap	Assets Assets	89300331	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	935351	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	871887	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2827862	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3559981	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1214640	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1357924	usd
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	215119	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	219844	usd
CY2023Q2	us-gaap	Loans Payable Current LoansPayableCurrent	6515776	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	535684	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	26505	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	11735253	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6545320	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	7632998	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	225282	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	7858280	usd
CY2023Q2	us-gaap	Liabilities Liabilities	11735253	usd
CY2022Q4	us-gaap	Liabilities Liabilities	14403600	usd
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	149	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	150	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	67215159	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	67215159	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	55963334	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	55963334	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	6724	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	5596	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	161864055	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	151163909	usd
CY2023Q2	qubt	Apic Beneficial Conversion Feature In Equity APICBeneficialConversionFeatureInEquity	4898835	usd
CY2022Q4	qubt	Apic Beneficial Conversion Feature In Equity APICBeneficialConversionFeatureInEquity	4898835	usd
CY2023Q2	qubt	Apic Stock Based Compensation APICStockBasedCompensation	43279140	usd
CY2022Q4	qubt	Apic Stock Based Compensation APICStockBasedCompensation	38816022	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-133136366	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-119987781	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	76912537	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	74896731	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	88647790	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	89300331	usd
	us-gaap	Revenues Revenues	232719	usd
	us-gaap	Revenues Revenues	96724	usd
CY2023Q2	us-gaap	Revenues Revenues	112190	usd
CY2022Q2	us-gaap	Revenues Revenues	65484	usd
	us-gaap	Cost Of Revenue CostOfRevenue	107395	usd
	us-gaap	Cost Of Revenue CostOfRevenue	16800	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	51157	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	5233	usd
	us-gaap	Gross Profit GrossProfit	125324	usd
	us-gaap	Gross Profit GrossProfit	79924	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	61033	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	60251	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1984322	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2474634	usd
CY2023Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	530689	usd
CY2022Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1358406	usd
	qubt	Consulting Expenses ConsultingExpenses	408322	usd
	qubt	Consulting Expenses ConsultingExpenses	626513	usd
CY2023Q2	qubt	Consulting Expenses ConsultingExpenses	183281	usd
CY2022Q2	qubt	Consulting Expenses ConsultingExpenses	255631	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3119308	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1875031	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1584712	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	850444	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3915625	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3403662	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1946811	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	323859	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2344352	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3217379	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	-325364	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2080275	usd
	us-gaap	Operating Expenses OperatingExpenses	11771929	usd
	us-gaap	Operating Expenses OperatingExpenses	11597219	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	3920129	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	4868615	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-11646605	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-11517295	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3859096	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4808364	usd
	us-gaap	Interest Income Other InterestIncomeOther	92980	usd
	us-gaap	Interest Income Other InterestIncomeOther	44027	usd
CY2023Q2	us-gaap	Interest Income Other InterestIncomeOther	61136	usd
CY2022Q2	us-gaap	Interest Income Other InterestIncomeOther	33163	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	400145	usd
CY2023Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	185623	usd
	qubt	Interest Expense Preferred Dividends InterestExpensePreferredDividends	430833	usd
	qubt	Interest Expense Preferred Dividends InterestExpensePreferredDividends	446250	usd
CY2023Q2	qubt	Interest Expense Preferred Dividends InterestExpensePreferredDividends	215119	usd
CY2022Q2	qubt	Interest Expense Preferred Dividends InterestExpensePreferredDividends	223125	usd
	us-gaap	Financing Interest Expense FinancingInterestExpense	763982	usd
	us-gaap	Financing Interest Expense FinancingInterestExpense	318750	usd
CY2023Q2	us-gaap	Financing Interest Expense FinancingInterestExpense	443746	usd
CY2022Q2	us-gaap	Financing Interest Expense FinancingInterestExpense	106250	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1501980	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-720973	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-783352	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-296212	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13148585	usd
	us-gaap	Net Income Loss NetIncomeLoss	-12238268	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-4642448	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-5104576	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	67215159	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29204543	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	67215159	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29204543	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	88937925	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44949871	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	88937925	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	44949871	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.2
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.42
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16201898	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	212500	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2985453	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-7133692	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	12266159	usd
CY2022Q2	qubt	Merger Consideration MergerConsideration	83083867	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	106250	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	229510	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-5104576	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	90581210	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	74896731	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6551455	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	2325000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	596	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1675707	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-8506137	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	76943352	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	8116636	usd
CY2023Q2	qubt	Merger Consideration MergerConsideration	-3600315	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2030277	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-1934966	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-4642448	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	76912537	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13148585	usd
	us-gaap	Net Income Loss NetIncomeLoss	-12238268	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	105137	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7342	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	-167505	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	249884	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	4096018	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3214962	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	248172	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	108616	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	83969	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-22139	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-78120	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	94001	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	103308	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-930895	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-382140	usd
	qubt	Increase Decrease In Preferred Dividends Payable IncreaseDecreaseInPreferredDividendsPayable	-4129	usd
	qubt	Increase Decrease In Preferred Dividends Payable IncreaseDecreaseInPreferredDividendsPayable	105671	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	5528	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-3385	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9788735	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8948475	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	581333	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10068	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	3947	usd
	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	504668	usd
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-1356071	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1089948	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1366139	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1901079	usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	318750	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	14668091	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12767012	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	318750	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1888329	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9995864	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5308466	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16738657	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7196795	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6742793	usd
	us-gaap	Interest Paid Net InterestPaidNet	598921	usd
	qubt	Common Stock Preferred Stock And Warrants Issued In Connection CommonStockPreferredStockAndWarrantsIssuedInConnection	-3600315	usd
	qubt	Common Stock Preferred Stock And Warrants Issued In Connection CommonStockPreferredStockAndWarrantsIssuedInConnection	83083867	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Note 1 – <span style="text-decoration:underline">Nature of the Organization and Business </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration:underline">Corporate History</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Quantum Computing Inc. (“QCi” or the “Company”) was formed in the State of Nevada on July 25, 2001, under its prior name, Ticketcart, Inc. The Company redomiciled to Delaware on February 22, 2018 and changed its name to Quantum Computing Inc. Effective July 20, 2018, the trading symbol for the Company’s common stock, par value $0.0001, on the OTC Market changed from “IBGH” to “QUBT”. On July 15, 2021 the Company uplisted to The Nasdaq Stock Market LLC. On June 16, 2022, the Company merged with QPhoton, Inc. (“QPhoton”), a developer of quantum photonic systems and related technologies and applications.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration:underline">Nature of Business</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is a developer of nanophotonic-based quantum technology, offering real-world, affordable commercial applications. The Company was founded in 2018 by leaders in supercomputing, mathematics, and computer programming to solve the enormous challenge with quantum computing in terms of the high cost and lengthy times required for quantum software development. While much of the market focuses on Quantum Processing Unit (QPU) hardware, the Company’s experts realized that the quantum marketplace and vendors were limiting access to quantum computers due to the complexity of programming them. At the present time, only a very limited number of highly specialized quantum experts are able to use software development toolkits (“SDKs”) to create these critical programs and applications. The Company’s flagship software solution, Qatalyst, has enabled subject matter experts (SMEs) to run existing software on quantum processing units without the need for specialized programming with SDKs. As a result of the merger with QPhoton in June 2022, the Company is now able to offer its software capability that is embedded within its new hardware offering of photonic quantum computing systems and related services.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Liquidity</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 28, 2022 the Company filed a shelf registration statement on Form S-3 under the Securities Act of 1933, as amended (the “Securities Act”), which was declared effective on November 8, 2022 (the “2022 shelf”). Under the 2022 Shelf at the time of effectiveness, the Company had the ability to raise up to $100 million by selling common stock, preferred stock, debt securities, warrants and units. On December 5, 2022, the Company entered into an At-the-Market Issuance Sales Agreement (the “ATM Agreement”) with Ascendiant Capital Markets, LLC (“Ascendiant”) relating to the sale of its common stock, and incorporated the ATM Agreement into the 2022 Shelf by amendment that was declared effective January 10, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the terms of the ATM Agreement, the Company may, but is not obligated to, offer and sell, from time to time, shares of common stock having an aggregate offering price of up to $25 million through Ascendiant. Sales of common stock, if any, will be made by any method permitted that is deemed an “at the market offering” as defined in Rule 415 under the Securities Act. The Company intends to use any net proceeds from the sale of securities for our operations and for other general corporate purposes, including, but not limited to, capital expenditures, general working capital, and possible future acquisitions. There were 8,910,729 shares of common stock sold under the ATM Agreement during the six months ended June 30, 2023 and no shares of common stock sold under the ATM Agreement during the six months ended June 30, 2022. As of June 30, 2023, the Company has utilized $14.7 million of the 2022 Shelf. The Company has approximately $85.3 million available under the 2022 Shelf and $10.3 million available under the ATM Agreement as of June 30, 2023.</p>
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	100000000	usd
	qubt	Aggregate Offering Price AggregateOfferingPrice	25000000	usd
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	8910729	shares
	qubt	Company Shelf Description CompanyShelfDescription	As of June 30, 2023, the Company has utilized $14.7 million of the 2022 Shelf. The Company has approximately $85.3 million available under the 2022 Shelf and $10.3 million available under the ATM Agreement as of June 30, 2023.
CY2023Q2	us-gaap	Deferred Revenue DeferredRevenue	232719	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	16314701	usd
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	9788735	usd
CY2023Q2	us-gaap	Other Additional Capital OtherAdditionalCapital	3698666	usd
CY2023Q2	us-gaap	Cumulative Earnings Deficit CumulativeEarningsDeficit	136302482	usd
CY2023Q2	us-gaap	Deposits Money Market Deposits DepositsMoneyMarketDeposits	5335120	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration:underline">Use of Estimates:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These financial statements have been prepared in accordance with accounting principles generally accepted in the United States which requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Some of the more significant estimates required to be made by management include the determination of reserves for accounts receivable, stockholders’ equity-based transactions and liquidity assessment. Actual results may differ from these estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q2	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	67215159	shares
CY2022Q2	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	29204543	shares
	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	1564505	shares
	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	1575004	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	6464524	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	8594796	shares
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	13693737	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	5575528	usd
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	88937925	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	44949871	shares
CY2023Q2	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
	qubt	Stock Issued During Period Shares Stock Option Exercised StockIssuedDuringPeriodSharesStockOptionExercised	7028337	shares
CY2023Q2	us-gaap	Long Term Debt Term LongTermDebtTerm	P5Y
CY2023Q2	us-gaap	Investment Interest Rate InvestmentInterestRate	0.028	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.0354	pure
	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	0.00001	usd
	qubt	Transaction Amount TransactionAmount	83083868	usd
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	81939939	usd
CY2023Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	16109	usd
CY2023Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	116315	usd
CY2023Q2	us-gaap	Security Deposit Liability SecurityDepositLiability	97768	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	2722000	usd
	us-gaap	Capitalized Computer Software Period Increase Decrease CapitalizedComputerSoftwarePeriodIncreaseDecrease	969000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	12200000	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-2888246	usd
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	68706993	usd
CY2022Q2	qubt	Intangible Assets Goodwill IntangibleAssetsGoodwill	9581220	usd
CY2022Q2	qubt	Initial Valuation Estimate InitialValuationEstimate	25472220	usd
CY2022Q2	qubt	Final Valuation FinalValuation	15891000	usd
CY2022Q2	qubt	Increase Decrease IncreaseDecrease	-9581220	usd
	qubt	Purchase Price Amount PurchasePriceAmount	68700000	usd
CY2022Q1	us-gaap	Debt Instrument Annual Principal Payment DebtInstrumentAnnualPrincipalPayment	1250000	usd
CY2022Q2	us-gaap	Investment Sold Not Yet Purchased Balance Principal Amount InvestmentSoldNotYetPurchasedBalancePrincipalAmount	1250000	usd
CY2022Q2	us-gaap	Loans Assumed1 LoansAssumed1	2500000	usd
CY2022Q1	us-gaap	Investment Interest Rate InvestmentInterestRate	0.06	pure
CY2022Q2	us-gaap	Investment Interest Rate InvestmentInterestRate	0.15	pure
CY2023Q1	qubt	Extension Year ExtensionYear	P1Y
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3080990	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3248495	usd
CY2023Q2	us-gaap	Other Indefinite Lived Intangible Assets OtherIndefiniteLivedIntangibleAssets	12810010	usd
CY2022Q4	us-gaap	Other Indefinite Lived Intangible Assets OtherIndefiniteLivedIntangibleAssets	22223725	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	167506	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	3248495	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1421995	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2843991	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2352518	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1936657	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1831682	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	2423167	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	12810010	usd
CY2023Q2	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	65106678	usd
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	59125773	usd
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	9581220	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	59125773	usd
CY2023Q2	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	3600315	usd
CY2023Q2	us-gaap	Goodwill Gross GoodwillGross	65106678	usd
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	59125773	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	3600315	usd
	us-gaap	Goodwill Other Increase Decrease GoodwillOtherIncreaseDecrease	9581220	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1045718	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	175686	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	70549	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	11689399	usd
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	6921161	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	11689399	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6921161	usd
CY2023Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	11689399	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1627050	usd
CY2023Q2	us-gaap	Property Plant And Equipment Owned Net PropertyPlantAndEquipmentOwnedNet	1451364	usd
CY2022Q4	us-gaap	Property Plant And Equipment Owned Net PropertyPlantAndEquipmentOwnedNet	975169	usd
	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	581332	usd
CY2023Q2	qubt	Property Plant And Equipment Collections Capitalized PropertyPlantAndEquipmentCollectionsCapitalized	2500	usd
CY2021Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	200592	usd
CY2021Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	150000	usd
CY2021Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	150000	usd
CY2021Q1	us-gaap	Other Notes Payable OtherNotesPayable	500592	usd
CY2021Q1	us-gaap	Other Notes Payable OtherNotesPayable	500592	usd
CY2021Q3	us-gaap	Other Notes Payable OtherNotesPayable	500592	usd
CY2023Q2	us-gaap	Maturity Of Time Deposits MaturityOfTimeDeposits	P2Y
	us-gaap	Proceeds From Sales Of Business Affiliate And Productive Assets ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets	375000	usd
CY2022Q3	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	8250000	usd
CY2022Q3	us-gaap	Investment Interest Rate InvestmentInterestRate	0.10	pure
CY2022Q3	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	750000	usd
CY2022Q3	qubt	Outstanding Balance OutstandingBalance	1.20	pure
	qubt	Redemption Amount RedemptionAmount	750000	usd
CY2023Q2	us-gaap	Certain Loans Acquired In Transfer Accounted For As Available For Sale Debt Securities Outstanding Balance CertainLoansAcquiredInTransferAccountedForAsAvailableForSaleDebtSecuritiesOutstandingBalance	2500000	usd
CY2023Q2	us-gaap	Derivative Variable Interest Rate DerivativeVariableInterestRate	0.15	pure
CY2023Q2	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	2000000	usd
CY2023Q2	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	500000	usd
CY2023Q2	us-gaap	Percentage Of Debt Hedged By Interest Rate Derivatives PercentageOfDebtHedgedByInterestRateDerivatives	0.10	pure
CY2023Q2	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	5.5
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	7
CY2022Q2	us-gaap	Conversion Of Stock Description ConversionOfStockDescription	one of the Series A Investors, Falcon Capital Partners, converted 45,455 shares of Series A Convertible Preferred stock into 47,728 shares of common stock.
CY2022Q4	qubt	Merger Agreement Description MergerAgreementDescription	the Company issued 155,000 shares of common stock to seven employees and consultants in exchange for services rendered.
CY2023Q2	us-gaap	Common Stock Shares Held In Employee Trust Shares CommonStockSharesHeldInEmployeeTrustShares	853600	shares
CY2023Q2	us-gaap	Common Stock Shares Held In Employee Trust Shares CommonStockSharesHeldInEmployeeTrustShares	23900	shares
CY2023Q2	us-gaap	Common Unit Issued CommonUnitIssued	3000000	shares
CY2022Q3	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	16000000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	9601237	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	3.42
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	4342500	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.64
	qubt	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm1	P5Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	250000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.83
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	13693737	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	3.33
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P3Y10M24D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	7433424	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	3.37
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y6M
CY2023Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	13693737	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	7433424	shares
CY2022Q4	us-gaap	Share Price SharePrice	1.42
CY2021Q4	us-gaap	Share Price SharePrice	2.38
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	1616856	usd
CY2022	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	2758465	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2298769	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15003002	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	3915625	usd
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	17761467	usd
	qubt	Common Stock Options CommonStockOptions	9000000	usd
	qubt	Expected To Be Recognized Over A Period ExpectedToBeRecognizedOverAPeriod	P3Y10M24D
CY2020Q3	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	171000	shares
CY2020Q3	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	2
CY2021Q4	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	1545459	shares
CY2021Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	7
CY2022Q2	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	6325503	shares
CY2022Q2	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	0.0001
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	142843	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	344732	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	341081	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	349608	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	267092	usd
CY2023Q2	qubt	Imputed Interest ImputedInterest	307874	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1137480	usd
	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	217543	usd
CY2022	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	125238	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y2M12D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y8M12D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10	pure
	qubt	Consideration Agreement Description ConsiderationAgreementDescription	As consideration for the license and other rights granted under the agreement, QPhoton agreed to pay the following: (i) $35,000 within 30 days of execution of the agreement, (ii) $28,000 within 30 days of each annual anniversary of the effective date, (iii) equity in the Company equivalent to nine percent of the outstanding equity of the Company within 30 days of the execution of the agreement, and (iv) royalties of 3.5% of the net sales price of each licensed product sold or licensed by the company during the quarter then-ended, for which it also received payment, concurrent with the delivery of the relevant quarterly report.
CY2023Q3	qubt	Subcontract Received SubcontractReceived	122200	usd
	us-gaap	Demutualization By Insurance Entity Securities Issued Gross Cash Proceeds DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds	7803061	usd
	us-gaap	Property Management Fee Percent Fee PropertyManagementFeePercentFee	0.03	pure
CY2022Q4	us-gaap	Loans Receivable With Fixed Rates Of Interest1 LoansReceivableWithFixedRatesOfInterest1		usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent		usd
CY2023Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent		usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent		usd
	us-gaap	Interest Expense Debt InterestExpenseDebt		usd
CY2022Q2	us-gaap	Interest Expense Debt InterestExpenseDebt		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation		usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2022Q2	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
CY2022Q2	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants		usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation		usd
CY2023Q1	qubt	Merger Consideration MergerConsideration		usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities		usd
	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable		usd
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations		usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2021Q4	us-gaap	Goodwill Gross GoodwillGross		usd
CY2022Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss		usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q2	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	53568.44	usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	qubt	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercised Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm1
	qubt	Sharebased Compensation Arrangement By Sharebased Payment Award Options Forfeited Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm1
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001758009

Files In Submission

Name	View Source	Status
qubt-20230630_def.xml	Edgar Link	unprocessable
0001213900-23-067059-index-headers.html	Edgar Link	pending
0001213900-23-067059-index.html	Edgar Link	pending
0001213900-23-067059.txt	Edgar Link	pending
0001213900-23-067059-xbrl.zip	Edgar Link	pending
f10q0623ex31-1_quantum.htm	Edgar Link	pending
f10q0623ex31-2_quantum.htm	Edgar Link	pending
f10q0623ex32-1_quantum.htm	Edgar Link	pending
f10q0623ex32-2_quantum.htm	Edgar Link	pending
f10q0623_quantumcomp.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
qubt-20230630.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
qubt-20230630_lab.xml	Edgar Link	unprocessable
qubt-20230630_pre.xml	Edgar Link	unprocessable
qubt-20230630_cal.xml	Edgar Link	unprocessable
f10q0623_quantumcomp_htm.xml	Edgar Link	completed
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$QUBT
Quantum Computing Inc. Stock $qubt

2023 Q3 Form 10-Q Financial Statement

#000121390023067059 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QUBT Quantum Computing Inc. Stock $qubt

2023 Q3 Form 10-Q Financial Statement

#000121390023067059 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QUBT
Quantum Computing Inc. Stock $qubt